Now showing items 1-1 of 1

    • Translating molecular advances in Down syndrome and Fragile X syndrome into therapies. 

      Faundez, V; De Toma, I; Bardoni, B; Bartesaghi, R; Nizetic, D; de la Torre, R; Cohen Kadosh, R; Herault, Y; Dierssen, M; Potier, M-C (2018-06)
      Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested ...